The typical cancer vaccines involve in exogenously administrating tumor antigens with adjuvants, which could be delivered to antigen‐presenting cells (APCs), predominantly dendritic cells (DCs), inducing strong CD4+ T cells and cytotoxic T lymphocytes (CTLs) responses to eliminate tumor cells.6 This evidence concerns the gene CD4 and neoplasm.